These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1611016)

  • 61. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension.
    Rockey DC; Chung JJ
    Gastroenterology; 1998 Feb; 114(2):344-51. PubMed ID: 9453496
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intraportal administration of glyceryl trinitrate or nitroprusside exerts more systemic than intrahepatic effects in anaesthetised cirrhotic rats.
    Van de Casteele M; Hösli M; Sägesser H; Reichen J
    J Hepatol; 1999 Aug; 31(2):300-5. PubMed ID: 10453944
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Decreased hepatic glucose production in rats with carbon tetrachloride-induced cirrhosis.
    Krähenbühl S; Reichen J
    J Hepatol; 1993 Aug; 19(1):64-70. PubMed ID: 8301044
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Normal increase in glucose output by portal noradrenaline and glucagon but not nerve stimulation with enhanced portal resistance, not only in micronodular but also in intermediate thioacetamide cirrhotic livers.
    Gardemann A; Zimmermann T; Machnik G; Dargel R; Jungermann K
    Hepatology; 1993 Dec; 18(6):1544-5. PubMed ID: 8244284
    [No Abstract]   [Full Text] [Related]  

  • 65. Combined treatment of portal hypertension with ritanserin and propranolol in conscious and unrestrained cirrhotic rats.
    Pomier-Layrargues G; Giroux L; Rocheleau B; Huet PM
    Hepatology; 1992 May; 15(5):878-82. PubMed ID: 1568730
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Changes in blood flow, portal pressure and shunting during the development of cirrhosis in response to beta-blockade.
    McLaren M; Braye S; Fleming J; Karran S; Taylor I
    Gut; 1987 Jun; 28(6):663-7. PubMed ID: 2887489
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Establishment of a hepatic cirrhosis and portal hypertension model by hepatic arterial perfusion with 80% alcohol.
    Wang L; He FL; Liu FQ; Yue ZD; Zhao HW
    World J Gastroenterol; 2015 Aug; 21(32):9544-53. PubMed ID: 26327762
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Liver function improvement following increased portal blood flow in cirrhotic rats.
    Cardoso JE; Giroux L; Kassissia I; Houssin D; Habib N; Huet PM
    Gastroenterology; 1994 Aug; 107(2):460-7. PubMed ID: 8039623
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hepatic microcirculation in the perfused cirrhotic rat liver.
    Varin F; Huet PM
    J Clin Invest; 1985 Nov; 76(5):1904-12. PubMed ID: 4056057
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hemodynamic characteristics of the intrahepatic portal vascular bed over an extended flow range: a study in the isolated perfused rat liver.
    Grossman HJ; Grossman VL; Bhathal PS
    Hepatology; 1995 Jan; 21(1):162-8. PubMed ID: 7806151
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of interferon gamma on intrahepatic haemodynamics of the cirrhotic rat liver.
    Grossman HJ; White D; Grossman VL; Bhathal PS
    J Gastroenterol Hepatol; 1998 Oct; 13(10):1058-60. PubMed ID: 9835324
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of vasodilators on hepatic microcirculation in cirrhosis: a study in the isolated perfused rat liver.
    Marteau P; Ballet F; Chazouillères O; Chrétien Y; Rey C; Petit D; Poupon R
    Hepatology; 1989 Jun; 9(6):820-3. PubMed ID: 2714734
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Portal and arterial free and conjugated noradrenaline in two models of portal hypertension in rats.
    Gaudin C; Ruget G; Braillon A; Selz F; Cuche JL; Lebrec D
    Life Sci; 1989; 45(15):1333-9. PubMed ID: 2796605
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pressure-flow relationships and effects of noradrenaline and isoprenaline on the hepatic arterial and portal venous vascular beds of the dog.
    Richardson PD; Withrington PG
    J Physiol; 1978 Sep; 282():451-70. PubMed ID: 722550
    [TBL] [Abstract][Full Text] [Related]  

  • 75. IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats.
    Zhao TY; Su LP; Ma CY; Zhai XH; Duan ZJ; Zhu Y; Zhao G; Li CY; Wang LX; Yang D
    BMC Gastroenterol; 2015 Jul; 15():77. PubMed ID: 26152281
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [An experimental study of regional spontaneous portasystemic shunt in cirrhotic rats].
    Huang Y; Fan L
    Zhonghua Wai Ke Za Zhi; 1996 Mar; 34(3):133-7. PubMed ID: 9387663
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serum ammonia levels in response to glycine infusion in normal and cirrhotic rats.
    Frink EJ; DiGiovanni DA; Davis JR; Brown BR
    Anesth Analg; 1989 Dec; 69(6):776-82. PubMed ID: 2589660
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hemodynamics in the microvasculature of thioacetamide-induced cirrhotic rat livers.
    Nakata M; Nakamura K; Koda Y; Kaminou T; Ugami M; Kaneda K; Yamada R
    Hepatogastroenterology; 2002; 49(45):652-6. PubMed ID: 12063962
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
    Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
    Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evidence against a role for NADPH oxidase modulating hepatic vascular tone in cirrhosis.
    Gracia-Sancho J; Laviña B; Rodríguez-Vilarrupla A; Brandes RP; Fernández M; Bosch J; García-Pagán JC
    Gastroenterology; 2007 Sep; 133(3):959-66. PubMed ID: 17854599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.